[Editorial] GoGoVax dispels hopes for gonorrhoea vaccination
Summary
In 2020, WHO estimated that there were 82·4 million new infections with Neisseria gonorrhoeae among adults aged 15–49 years and up to 2022, the incidence of gonorrhoea had been on the rise globally for a decade. While in the last three years a decrease in the number of cases has been observed in several countries, including the USA and the UK, with antimicrobial resistance constituting a major barrier to treatment a…
In 2020, WHO estimated that there were 82·4 million new infections with Neisseria gonorrhoeae among adults aged 15–49 years and up to 2022, the incidence of gonorrhoea had been on the rise globally for a decade. While in the last three years a decrease in the number of cases has been observed in several countries, including the USA and the UK, with antimicrobial resistance constituting a major barrier to treatment and no gonorrhoea vaccine available, protecting populations at risk from the disease remains a challenge.